#Uterine Cancer Drugs

[coochiequeens]

Boycott the beauty industry. Ladies in jobs where you get more tips if you wear makeup please look at the ingredients

May 8, 2025 By Ronnie Cohen

A study recruited Black and Latina women and asked them to log all the beauty products they use in a week. More than half of the women used products with known carcinogens.

More than half of Black and Latina women in Los Angeles who participated in a new study regularly used personal-care products containing a known carcinogen.

Study participants photographed the ingredient lists of all the products they used at home over the course of a week. The journal Environmental Science & Technology Letters published the study Wednesday.

Of 64 women, researchers found that 53% reported using soap, lotion, shampoo, conditioner, skin lightener, eyeliner, eyelash glue and other beauty products that contained formaldehyde and formaldehyde-releasing preservatives — toxins found to cause cancer in humans.

"It's really concerning that we are intentionally putting chemicals that release a carcinogen into our products that we apply to ourselves every day," said lead author Robin Dodson, associate director of research at Silent Spring Institute, a Massachusetts nonprofit studying environmental causes of breast cancer.

"Formaldehyde is a great preservative," she said. "That's why it's used as an embalming fluid. And we do have to remember formaldehyde is a carcinogen."

The study is among the first to demonstrate that formaldehyde-releasing preservatives are present in a wide range of beauty products.   The research, collected in 2021, focused on Black and Latina women after previous studies showed they are more often exposed to formaldehyde in nail and hair products than white women. Researchers have questioned whether African American women's frequent use of chemical hair straighteners, suspected of containing formaldehyde-releasing agents, might explain why breast, uterine and ovarian cancers kill disproportionately more Black than white women.

In 2023, a dozen years after a federal agency classified formaldehyde a human carcinogen, the Food and Drug Administration was tentatively scheduled to unveil a proposal to consider banning the chemical in hair straighteners. Two years later, the government still has failed to act. The FDA declined to comment.

The new study shows that formaldehyde and formaldehyde-releasing products are present not only in hair relaxers but in a wide variety of beauty products, including some that women apply to their bodies far more frequently than chemical hair straighteners.

One study participant used three formaldehyde products: a leave-in conditioner, a rinse-off conditioner and a body wash. Another participant washed with hand soap with formaldehyde-releasing agents an average of twice a day.

An array of products

The sheer number of products — 1,143 over seven days — the 64 participants used struck Tracey Woodruff, who directs the University of California at San Francisco's Program on Reproductive Health and the Environment. The women in the study used an average of 17 different products a day — as few as 5 and as many as 43.

"It speaks to the pressure women have to look a certain way," said Woodruff, who was not involved with the new research.   Social and economic pressures frequently compel Black women to alter their appearance to conform to white beauty standards, said study co-author Janette Robinson Flint, executive director of Black Women for Wellness. She called for government oversight of personal-care products. "We shouldn't have to be chemists to figure out what kinds of products will make us sick," she said. 

"Beauty norms that focus on white presentation definitely are resulting in people using products that can be harmful to their health," Woodruff said. "This is part of the legacy and history of discrimination against the Black and Latinx population." 

Woodruff would have liked the study to also compare product use by white women in an effort to assess whether beauty-product use is contributing to health inequities.

Woodruff and Dodson joined Flint in calling for government oversight and regulation of cosmetics and other personal-care products.

Banned in Europe

In addition to being a carcinogen, formaldehyde, a colorless and smelly gas, can cause rashes and can sicken those who breathe it in, according to the FDA. Formaldehyde-releasing products need not be listed as formaldehyde on ingredient labels. Instead, they are listed by their chemical names, such as DMDM hydantoin, short for 1,3-dimethylol-5,5-dimethylhydantoin, which, as Dodson noted, doesn't exactly roll off the tongue. 

The European Union banned formaldehyde as a cosmetic ingredient in 2009, and any cosmetic product containing a formaldehyde-releasing preservative above a miniscule concentration must include a warning. At least 12 states, including California and Washington, have recently proposed or enacted laws to regulate the use of formaldehyde in cosmetics. 

How well the laws will protect consumers remains to be seen. Reports to the California Department of Public Health's Safe Cosmetics Program do show a tenfold drop in products containing formaldehyde from 2009 to 2022.

"In the very near short term, tomorrow, I think consumers should do the best they can to read product labels," Dodson said. "In the longer term, I think there has to be a regulatory solution. It has to come down to ingredient bans, likely at the state level."

[lazulisong]

I talked to my surgeon about how triggering an internal scan would be and we decided to go external only. Not that it mattered because they didn't have any appointments available until after my surgery and so we didn't have an ultrasound done at all. (I'm assuming that the ultrasound is related to hysterectomy prep, disregard this message if I'm wrong.)

It is but the problem is that my mother was a DES* baby and had a positive pap plus a rather large benign ovary tumor and my sister had andemiosis (like endometriosis but in the muscle) AND a maternal first cousin straight up had uterine cancer so even if the doctor was willing I actually kind of need to be screened for you know. surprises. So even if I could get away with not doing the internal one it's wiser to drug myself up and get through it 😭 trauma is bad! Cancer is worse!!!!!

right now my amygdala is throwing a rager but I know it'll be much less stressful when it's done. But you bet I'll be drugged to the gills.

*artificial estrogen used because they thought it made pregnancies stable and uhhhhhh surprise! It did not. Also it's a cross placental mutagen and it's high key a medical miracle that my mother ever had kids let alone carried Amy and I to term. Look it up, it's like three parts fascinating and ten parts horrifying

[messrsrarchives]

Heyyy You explain these things in ways I can actually understand is it insensitive to ask about the blocker ban? And I hope you haven't been affected by any of it and that you are okay 💖💖💖

HI !! i'm gonna be so honest and say that my initial response was going to be that i can't. and,,, i can't really.

but the corner feels really empty at the moment. which,,, i know it's not. but it's really fucking lonely both in and out of this space to be trans right now so i'm gonna make this corner mine 🙂↕️ let's talk about it.

to preface - it's so much deeper than everything below. it's,,, i haven't been hurt by the ban of puberty blockers but since they've made it indefinite, i've been taken off of all care. from my seizures to my mental health to even just "if i broke my leg right now, where the fuck do i go???". which,,, fucking sucks init. i thought maybe it was just a Me thing and i'd gotten unlucky with my gp, but all bar one of my trans friends have been taken off of everything. so,,, not directly no. but this isn't just an attack on Trans Healthcare, this is an attack on trans people receiving any healthcare. oh and they changed my name back to my deadname on the database without telling me. so that's. something.

yeah. it fucking sucks. eloquent, i know but idk. no words for it really and you've sent this at 4am which is prime crying time so 🫂🫂 thank you for checking in 🫂🫂

but now that the sob session is over, onto the important things:

THE BASICS:

puberty blockers: used to postpone puberty, once taken off of these puberty proceeds as normal.

these are not predominately a form of trans healthcare and can be used for: early onset puberty (affects v roughly 1 in 5-10,000), endometriosis (growth of uterine lining, incredibly painful condition), some forms of cancer - and some other things but these are the most common uses

these have been used commonly since the 80s to treat such things with no question in regards to their safety (because, spoiler alert: this isn't actually about the safety of them, it's about transphobia)

the ban only applies to gender dysphoria cases: note here, at the time of the original ban only 83 cases of this were being prescribed. more cis people were on them than trans people.

to clarify, in case it wasn't clear how blatant the transphobia is: puberty blockers do not function differently on trans people. healthcare does not discriminate, the system does.

TIMELINE:

MARCH 2024: nhs england decides that blockers will no longer be routine treatment for gender dysphoria

APRIL 2024: final cass report released -> more below but this was a review into gender identity services for under-18s, written by someone who hates trans people,,, i'm sure that won't be biased at all ! /s

MAY 2024: previous tory government tightens this and introduces an "emergent temporary ban" (those already on the drug are allowed to continue)

JULY 2024: labour gov comes into power and keep it in place. law is challenged in the high court, government wins.

AUGUST 2024: "temporary" ban extended again

NOW: wes streeting (health secretary) has made this indefinite with a review in 2027.

EXTRA DETAILS:

this comes from "expert advice" including the Cass Report. i'll link a review by Stonewall Scotland here but the general synopsis is that this is written by a terf who did not communicate with trans individuals, has no fucking clue what actually happens, and is completely fucking wrong about everything. government (both previous and current) approve this review 😄👍🏼 -PSSTTT so does jkr, she said she felt "vindicated" by this)

there are planned clinical trials by the nhs into the use of puberty blockers (will these happen? who knows! will they be fair? absolutely not, the nhs started this and have been cutting their trans services for fucking ages)

backed by Sex Matters (incrediblyyy transphobic organisation and PSSSTTTT jkr is connected to them! anyway :3 here's a quote from them -> "It marks another step towards puberty blockers being relegated to a shameful chapter of history, in which parents and health professionals were emotionally blackmailed into harming children in the name of 'progress'."

this here is a response from Trans Actual -> note, this is from the august extension, i'm unsure if they've responded to the indefinite ban yet.

there's most definitely more but i've spent too long looking at my google doc. i hope this helped explain it a little !!

it's all incredibly baseless with no evidence of the harm these "cause", but plenty of evidence on the harm the ban causes. it's blatant transphobia no matter how much they phrase it as "protecting kids"

[homara8524]

Status Report and Mail Order Notification

Good evening brothers and sisters abroad. After the rush of events, I am finally getting settled. Today, I'd like to give you an update on my recent activities and announce the mail order of my original drawings and new publications.

The rush of events started on September 15. It all started with my best friend from high school and I going to LUPICIA, a famous Japanese tea company, to get some tea cakes for the upcoming events.

On 9/23, I exhibited at a joint Touhou event in Kyoto to display and distribute my new book and original artwork, and on 9/30, I was asked to be a second for my master's powerlifting competition, so I was engaged in seconding.

After that, I participated in Kouroumu, a Touhou event held in Osaka, where I exhibited and distributed my original artwork. I have now been working at the event for 4 weeks in a row.

And now that things have finally settled down, we have registered our new publications and original artwork on our mail order site! We have also registered them with the proxy purchase service in Booth's system so that they can be purchased by people overseas. We will charge a small fee for this service, but it will be available to anyone overseas. Of course they will be framed 💕.

In fact, we also have new postcard-sized original drawings of Eastern characters that we have not yet posted here on our website.

And here is a request for the future. My circle currently consists mainly of Touhou character illustrations, but I have started to work on original illustrations as well. And now I am raising funds for my hospitalization and surgery to remove my uterine cancer.

The date for the surgery itself has already been set, and after I finish a national powerlifting competition next month, I will be hospitalized for a little less than two weeks from November 20 to observe the surgery and post-operative condition.

Currently, due to a worsening of a chronic illness that occurred the year before last, I am unable to engage in normal work, and I am still unable to engage in any work other than drawing illustrations. I am a freelance illustrator and earn almost no income. I do not have enough money to face the hospitalization and surgery next month.

So I would like to ask my overseas followers to help me. Please spread the word about my original illustrations to people who are not just Touhou lovers. And if you think it is a wonderful work of art, whether you like the character or not, please welcome the original.

If as many people as possible welcome my original drawings and new publications, it will help to pay for my uterine cancer surgery and subsequent hospital visits.

Most importantly, it will also help fund the purchase of expensive immunosuppressive drugs for my uterine cancer and other incurable diseases.

Please, can you all help me?

[detransition]

"For years, Sharissa Derricott, 30, had no idea why her body seemed to be failing. At 21, a surgeon replaced her deteriorated jaw joint. She’s been diagnosed with degenerative disc disease and fibromyalgia, a chronic pain condition. Her teeth are shedding enamel and cracking.

None of it made sense to her until she discovered a community of women online who describe similar symptoms and have one thing in common: all had taken a drug called Lupron.

Thousands of parents chose to inject their daughters with the drug, which was approved to shut down puberty in young girls but also is commonly used off-label to help short kids grow taller.

The drug’s pediatric version comes with few warnings about long-term side effects. It is also used in adults to fight prostate cancer or relieve uterine pain and the Food and Drug Administration has warnings on the drug’s adult labels about a variety of side effects.

More than 10,000 adverse event reports filed with the FDA reflect the experiences of women who’ve taken Lupron. The reports describe everything from brittle bones to faulty joints.

In interviews and in online forums, women who took the drug as young girls or initiated a daughter’s treatment described harsh side effects that have been well-documented in adults.

Women who used Lupron a decade or more ago to delay puberty or grow taller described the short-term side effects listed on the pediatric label: pain at the injection site, mood swings and headaches. Yet they also described conditions that usually affect people much later in life. A 20-year-old from South Carolina was diagnosed with osteopenia, a thinning of the bones, while a 25 year-old from Pennsylvania has osteoporosis and a cracked spine. A 26 year-old in Massachusetts needed a total hip replacement. A 25-year-old in Wisconsin, like Derricott, has chronic pain and degenerative disc disease.

“It just feels like I’m being punished for basically being experimented on when I was a child,” said Derricott, of Lawton, Okla. “I’d hate for a child to be put on Lupron, get to my age and go through the things I have been through.”

Women fear drug they used to halt puberty led to health problems (PBS) graphic from woman-for-women | thinking of detransition? you are not alone

[eternal-echoes]

“In the early 1990s an "adventurous pediatric endocrinologist" in Amsterdam halted the puberty of a thirteen-year-old girl known as "B" by administering to her an off-label drug known as a gonad-otrophin-releasing hormone agonist, or GnRHa.(5) When administered to a child, it pauses the development of his or her secondary sex characteristics. For a girl, this means she will not experience normal breast development, menstruation, or typical fat distribution. A boy, meanwhile, will have lower muscle mass, less facial hair, decreased height, and his voice will not deepen.

At the time B received GnRHa, it was only used to chemically castrate male sex offenders and to treat prostate cancer. It has also been used to treat uterine fibroids and endometriosis in women-but for no longer than six months. Doctors also sometimes prescribed it to treat the rare condition of precocious puberty in children (when puberty begins before age eight in girls and before age nine in boys). However, such drugs were never approved for treating gender dysphoric children who were otherwise progressing naturally through puberty. After all, puberty is not a disease. In fact, the absence of puberty is a disease, known as Kallmann syndrome. When puberty blockers are given to healthy children, physicians are using drugs to induce a diseased state in the patient.”

-Jason Evert, Male, Female, or Other: A Catholic Guide to Understanding Gender

—

Work cited:

5) Cf. Michael Biggs, "The Tavistock's Experiment with Puberty Blockers," Department of Sociology and St. Cross College, University of Oxford (version 1.0.1), July 29, 2019; P. Cohen-Kettenis and S. van Goozen, "Pubertal Delay as an Aid in Diagnosis and Treatment of a Transsexual Adolescent," European Child & Adolescent Psychiatry 7 (1998), 246-248.

—

For more recommended resources on gender dysphoria, click here.

[justinspoliticalcorner]

Robyn Pennacchia at Wonkette:

Last week, Louisiana lawmakers empowered child rapists by voting down a bill that would have allowed an exception in their abortion ban for their victims. This week, they’re looking into classifying abortion pills as a Schedule IV “controlled substance” so that they can harshly prosecute people for helping to distribute them to those in need. The provision was added as an amendment to SB276, a bill that “creates the crime of coerced criminal abortion by means of fraud to prohibit a third-party from knowingly using an abortion-inducing drug to cause, or attempt to cause, an abortion on an unsuspecting pregnant mother without her knowledge or consent and amends various abortion criminal laws to add the crime of attempted abortion.”

It is deeply concerning that Louisiana legislators are wholly unaware that all of this is already illegal. It is illegal, except in some emergency situations and even then only by medical professionals, to give anyone any kind of medication without their knowledge and informed consent. If they think this is legal, well, I wouldn’t leave my drink around a single one of them, is all I’m saying. It’s also clear that they don’t really understand what controlled substances are, why some drugs are scheduled and others are not, nor anything about the specific drugs they are trying to control. Misoprostol, for instance, is primarily used to prevent ulcers from NSAIDs, as well as to help stop postpartum hemorrhaging after a miscarriage. Mifepristone is sometimes used during labor, during IUD placement, during cancer biopsies, for Cushing’s syndrome and uterine fibroids.

[...] The bill’s sponsor, Republican state Sen. Thomas Pressly, introduced it partially for personal reasons, because his sister’s ex-husband actually did secretly dose her with an abortion drug, and was not, in Pressly and his sister’s estimation, punished severely enough for it. He served 180 days in jail, and the bill would raise that to 10 years and up to $75,000 in fines. It would be one thing to increase the penalties for dosing anyone in any kind of way, but there’s a reason they’re specifying abortion drugs. What they want is to prevent people from getting them for women who want to take them voluntarily but cannot because of their state’s gross law, and to institute major penalties for this. What they want is to be able to better track doctors who may still be prescribing these pills to abortion-seeking patients for reasons other than abortion.

Louisiana's SB276 bill to classify abortion pills such as mifepristone and misoprostol as "controlled substances" are an attack on reproductive freedom and family planning.

[virtualelectronicshub]

Radiation Therapy Explained: Benefits, Process, and Potential Side Effects

Radiation therapy is a type of cancer treatment that uses high doses of radiation to kill cancer cells and shrink tumours. Radiation therapy works by damaging the DNA of cancer cells, which prevents them from dividing or growing. Radiation therapy can be delivered externally or internally, depending on the type and location of the cancer.

Radiotherapy is a rapidly growing technically advancing speciality.

The most advanced radiotherapy techniques include:

ETHOS, Linear Accelerators with Artificial Intelligence.

MR Linear Accelerators, where a MR imaging machine is used as part of treatment for better imaging and treatment position and precision.

Cyberknife:  A miniature linear accelerator mounted on a robotic arm, used for high precision radiotherapies to like brain tumors and recurrent tumors close to critical organs.  Cyberknife is used even in noncancerous brain tumors like schwannommas and trigeminal nerve roots alleviating the pain and suffering of trigeminal neuralgia.

Proton Beam Therapy.

3D conformal radiation therapy.

Intensity-modulated radiation therapy (IMRT)

Volumetric modulated radiation therapy (VMAT)

Image-guided radiation therapy (IGRT)

Stereotactic radiosurgery (SRS)

Brachytherapy.

Superficial x-ray radiation therapy (SXRT)

Intraoperative radiation therapy (IORT)

Benefits of Radiation Therapy

For many common cancers, such as breast cancer, bowel cancer, uterine cancer, skin cancers and prostate cancer, radiation therapy is highly effective in reducing the risk of cancer recurrence if delivered either before or after surgery. In some cancers (for example (prostate, head and neck, bladder, lung, cervix and skin cancers), radiation therapy, with or without drug therapy, can be used as the main curative treatment and in this way avoids the risks of surgery and the removal of organs.

For some cancers that are too advanced to be cured, radiation therapy is very effective for pain and other problems caused by cancer, such as bleeding from the lung or bladder. For example, pain in the bones from the spread of cancer can be improved significantly or be completely removed in around 75% of patients.

New technological advances in radiation therapy have made life better for cancer patients in recent years by making treatments even quicker, more accurate and effective.

Radiation therapy can help:

●      Cure cancer by destroying all the cancer cells in a tumour.

●      Control cancer by slowing down its growth or preventing it from spreading to other parts of the body.

●      Relieve symptoms such as pain, bleeding, or pressure caused by a tumour.

Process of Radiation Therapy

The process of radiation therapy varies depending on the type and stage of the cancer, the goals of the treatment, and the patient’s overall health and preferences. Generally, the process involves:

Radiation therapy is a type of cancer treatment that uses high energy beams to destroy cancer cells and shrink tumours.

The American Cancer Society notes that more than half of people with cancer receive radiation therapy.

Radiation damages genetic material called DNA inside of cancer cells. If the cancer cell cannot repair the DNA, the cell will not be able to produce new cells and may die.

The radiation may injure noncancerous cells, but most are able to recover.

A person’s treatment team will carefully plan radiation therapy to minimise damage to normal tissues and organs.

●  A consultation with a radiation oncologist, who is a doctor who specialises in treating cancer with radiation.

● A planning session is where a radiation therapist will keep the patient  immobilised in position with thermoplastic masks, then imaging tests such as CT scans or MRI scans are used to map out the exact location and size of the tumour and the surrounding normal tissues.

●  A simulation session, where a radiation therapist will position the patient on a table and mark the skin with ink or tattoos to guide the delivery of the radiation beams.

● A treatment session, where the patient will lie still on a table while a machine called a linear accelerator will deliver the radiation beams to the tumour from different angles. The treatment session may last from a few minutes to an hour, depending on the dose and type of radiation therapy. The patient may need to have several treatment sessions over days, weeks, or months.

Potential Side Effects of Radiation Therapy

Radiation therapy can cause side effects that vary depending on the part of the body being treated, the dose and type of radiation therapy, and the patient’s individual response. Some common side effects include:

●      Skin changes such as redness, dryness, itching, peeling, or blistering.

●      Fatigue or tiredness that may interfere with daily activities.

●      Nausea, vomiting, diarrhoea, or constipation that may affect appetite and    digestion.

●      Hair loss in the area being treated.

●      Mouth sores or dry mouth that may make eating or swallowing difficult.

●      Headaches or memory problems that may affect concentration or mood.

●      Inflammation or infection of the bladder or rectum that may cause pain or bleeding during urination or bowel movements.

Most side effects are temporary and will go away after the treatment is completed. However, some side effects may be long-lasting or permanent, such as infertility, nerve damage, lymphedema (swelling caused by fluid build-up), or secondary cancers.

Radiation therapy is an effective and safe way to treat many types of cancer. However, it is not suitable for everyone and it may have some risks and limitations. Therefore, it is important to discuss with your doctor about the benefits and drawbacks of radiation therapy for your specific situation before starting the treatment.

For more details click on the link 👇🏻 https://bit.ly/3osreVo

[unwelcome-ozian]

What information do you have about Johnson & Johnson?

Alza filed an NDA for the transdermal opioid analgesic product in December 1987 for post-operative use and for the relief of chronic cancer pain. Developed by J&J subsidiary Janssen Pharmaceutica, fentanyl has been marketed since 1968 under the Sublimaze brand. The drug is currently approved for I.V. administration and used primarily as a short-acting analgesic during anaesthesia. "This new drug delivery system will make it possible for the first time to use fentanyl . . . outside the operating room to control moderate to severe pain." Source

US opioids: Johnson and Johnson and drug distributors offer $26bn to end thousands of lawsuits. Source

The drug company Johnson & Johnson (J&J) has expressed regret after court documents unsealed in talcum powder litigation showed that it funded a 1971 study in which Pennsylvania prison inmates, most of them black, were injected subcutaneously with asbestos. Source

Asbestos Prisoner Study May Spell More Problems for Johnson & Johnson

WASHINGTON - Global health care giant Johnson & Johnson (J&J) and its subsidiaries will pay more than $2.2 billion to resolve criminal and civil liability arising from allegations relating to the prescription drugs Risperdal, Invega and Natrecor, including promotion for uses not approved as safe and effective by the Food and Drug Administration (FDA) and payment of kickbacks to physicians and to the nation’s largest long-term care pharmacy provider.  The global resolution is one of the largest health care fraud settlements in U.S. history, including criminal fines and forfeiture totaling $485 million and civil settlements with the federal government and states totaling $1.72 billion. Source

Johnson & Johnson paused all clinical trials of its experimental COVID-19 vaccine after a study participant became sick with an "unexplained illness."

Johnson & Johnson has suspended international trials of a drug in the same class as an experimental drug made by Portuguese pharmaceutical company Bial, whose tests in France left one person brain dead and five others hospitalised. Source

1982 - McNeil

Product Recalled - Tylenol (acetaminophen) capsules

Reason for Recall - Medicine laced with potassium cyanide (poison) resulting in several patient deaths.

2009 to 2011 - McNeil

Product Recalled - Several OTC medicines including Tylenol, Motrin, Benadryl, St. Joseph aspirin, Sudafed, Pepcid, Mylanta, Rolaids, Zyrtec, Zyrtec Eye Drops (tens of millions of bottles)

Reason for Recall - Unpleasant smells causing nausea; tiny metal shards in liquid medicines; wrong ingredient levels

2010 - DePuy [Pinnacle Systems]

Product Recalled - ASR Hip Resurfacing System and ASR XL Acetabular System (metal-on-metal hip implants)

Reason for Recall - Metal poisoning (metallosis); loosening of the implant or joint dislocation; additional surgeries

2012 - Ethicon

Product Recalled - Gynecare Prolift Kit, Gynecare Prolift+M Kit, Gynecare TVT Secure and Gynecare Prosima Pelvic Floor Repair System Kit (transvaginal mesh implants)

Reason for Recall - Perforation of organs; vaginal bleeding and scarring; mesh erosion; severe pain

2014 - Ethicon

Product Recalled - Power Morcellators

Reason for Recall - Spread of uterine cancer; rapid progression of the disease; death

2019 – Johnson & Johnson

Product Recalled – 33,000 bottles of Johnson’s Baby Powder

Reason for Recall – The FDA found a small amount of asbestos — a known carcinogen — in a sample

Xarelto

Number of Lawsuits - 13,511

Injuries - severe, sometimes deadly bleeding events, blood clots, wound leaks, infection

J&J was involved in seven of 2017’s top ten health-care-related verdicts.

The company was also involved in the third-largest pharmaceutical settlement with the U.S. Department of Justice. In 2013, J&J paid the Justice Department more than $2.2 billion. The settlement resolved civil and criminal allegations involving Risperdal, Invega and Natrecor.

May 2017

J&J paid $33 million to most U.S. states and the District of Columbia. The states charged J&J with misrepresenting the manufacturing practices behind certain drugs. This included its Motrin products. These products were later recalled.

Oz

[drshivanisachdevgoursciivf]

Demystifying Female Infertility: Exploring 5 Potential Causes

Female infertility is a complex condition that affects a significant number of women around the world. The inability to conceive can be emotionally challenging and often prompts a search for answers. While infertility can have various underlying causes, this article aims to shed light on five potential factors that may contribute to female infertility. By understanding these causes, individuals and healthcare professionals can work together to explore appropriate interventions and treatment options.

Hormonal Imbalances: One of the common causes of female infertility is hormonal imbalances. Hormones such as estrogen, progesterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) play vital roles in regulating the menstrual cycle and promoting ovulation. Any disruption in the delicate balance of these hormones can lead to irregular or absent ovulation, making it difficult for women to conceive.

Structural Abnormalities: Structural abnormalities within the reproductive system can also contribute to female infertility. Conditions such as polycystic ovary syndrome (PCOS), endometriosis, uterine fibroids, or blocked fallopian tubes can hinder the fertilization process or implantation of a fertilized egg. These conditions may require medical intervention or surgical procedures to restore fertility.

Age-related Factors: Advancing age is a significant factor that impacts female fertility. As women age, the quantity and quality of their eggs decline. The chances of chromosomal abnormalities and miscarriages increase, making it more challenging to conceive naturally. It is important for women to be aware of their reproductive timeline and seek assistance from healthcare professionals if they face difficulties in conceiving as they get older.

Lifestyle Factors: Certain lifestyle factors can contribute to female infertility. Obesity, excessive alcohol consumption, smoking, drug abuse, and high levels of stress can all have adverse effects on reproductive health. These factors can disrupt hormonal balance, interfere with ovulation, and affect the overall fertility of women. Adopting a healthy lifestyle that includes regular exercise, a balanced diet, and stress management techniques can positively impact fertility.

Medical Conditions and Treatments: Certain medical conditions and treatments can also cause infertility in females. Conditions such as thyroid disorders, autoimmune diseases, diabetes, and cancer can affect fertility. Additionally, treatments such as chemotherapy and radiation therapy can damage the reproductive organs and impair fertility. It is crucial for women with these conditions to consult with their healthcare providers to explore fertility preservation options before undergoing such treatments.

Conclusion: Understanding the potential causes of female infertility is crucial for women and healthcare professionals alike. By identifying these factors, individuals can take proactive steps to address and manage their reproductive health. It is important to remember that each case of infertility is unique, and a comprehensive evaluation by a healthcare professional is essential to determine the underlying cause and develop an appropriate treatment plan. With advancements in medical science and fertility treatments, many individuals can still achieve their dream of starting a family despite facing infertility challenges.

Looking for a Free IVF Consultation with an IVF Specialist? Contact Dr. Shivani Sachdev Gour.

[ayurzenith]

Shatavari: The Ayurvedic Queen of Feminine Health- First Herb in "Holistic Women’s Health with Ayurveda" Series

Introduction

Shatavari (Asparagus racemosus) isn’t just an herb-it’s a 5,000-year-old legacy of feminine empowerment. Celebrated in Ayurveda as the "Queen of Herbs," this adaptogenic powerhouse supports women from their first period to menopause. Let’s explore its science, soul, and practical uses.

Botanical Profile & History

• Botanical Name: Asparagus racemosus

• Family: Asparagaceae

• Key Part: Tuberous roots (rich in steroidal saponins like Shatavarin IV)

• Habitat: Native to India, Africa, and Australia (now endangered due to overharvesting).

Historical Roots:

Mentioned in the Rig Veda and Charaka Samhita, Shatavari’s Sanskrit name (“she with 100 husbands”) symbolizes its role in enhancing vitality and reproductive resilience.

How Shatavari Works: Mechanisms of Action

For Hormonal & Reproductive Health

•Phytoestrogenic Activity: Binds to estrogen receptors, balancing hormones during menstruation and menopause .

•Ovarian Support: Enhances follicular growth and reduces oxidative stress in ovarian tissues .

•Uterine Tonic: Inhibits oxytocin-induced contractions, easing menstrual cramps .

For Stress & Immunity

• Adaptogenic: Lowers cortisol by modulating the HPA axis .

• Immunomodulatory: Increases lymphocyte production for faster infection recovery .

Shatavari for Every Life Stage

During menstruation, Shatavari helps to reduce premenstrual syndrome (PMS) symptoms, regulate menstrual cycles, and ease cramps. Scientific research, including randomized controlled trials, has shown that women using Shatavari experienced up to a 45% improvement in PMS symptoms.

For fertility, Shatavari supports healthy ovulation and improves the thickness of the uterine lining, making it beneficial for women trying to conceive. In women with polycystic ovary syndrome (PCOS), studies have found that Shatavari use led to a 40% improvement in ovulation rates and enhanced endometrial thickness, both of which are important for fertility.

During pregnancy and the postpartum period, Shatavari is traditionally used to support uterine health and to boost milk production for breastfeeding mothers. Scientific studies have demonstrated that Shatavari can increase levels of the hormone prolactin by about 35%, which helps enhance breast milk supply.

In menopause, Shatavari helps to reduce hot flashes, vaginal dryness, and insomnia, making the transition smoother for women. Clinical trials have shown that women taking Shatavari experienced 50% fewer hot flashes and notable improvements in sleep quality and comfort during menopause.

DIY: Shatavari Moon Milk

Ingredients:

• 1 tsp Shatavari powder

• 1 cup warm milk (dairy or plant-based)

• Pinch of nutmeg + ½ tsp cardamom

• Honey to taste

Mechanism:

Shatavari’s mucilage soothes tissues, while its saponins enhance nutrient absorption.

Contraindications & Safety

✅ Safe For: Most adults (short-term use).

❌ Avoid If:

• Estrogen-sensitive cancers (may stimulate receptors)

• Heavy Kapha (sluggish digestion/weight gain)

• Asparagus allergies

Drug Interactions:

May potentiate hypoglycemic drugs; monitor blood sugar

Conclusion:

Shatavari is more than just a women’s herb-it’s a nurturing companion through every phase of womanhood. From easing period pain to supporting fertility, pregnancy, and menopause, this Ayurvedic gem empowers women to reclaim balance and vitality in a gentle, natural way. As you sip your Shatavari Moon Milk or embrace its rituals, remember: true feminine strength is both soft and resilient. Stay tuned as our Holistic Women’s Health with Ayurveda series continues, bringing you more ancient wisdom for modern wellness.

[zany1122]

Best IVF Specialist In India

IHR Kolkata, a well-respected fertility clinic in Kolkata, offers a wide range of fertility treatments including best ivf centre in india. In vitro fertilization (IVF), one of the world’s premier assisted reproductive technologies, offers couples suffering from infertility an effective solution. In the IVF procedure, the eggs from the ovaries of the woman are taken and fertilized in a lab dish with sperm. The embryos that are created will then be transferred into the uterus of the woman in order to achieve a successful pregnancy. IHR Kolkata offers IVF treatments by highly experienced doctors and embryologists who collaborate to offer customized care and assistance to couples undergoing IVF in Kolkata. With the help of IVF, couples experiencing infertility have an opportunity to conceive and begin building their family.

IVF treatment in Kolkata involves multiple stages such as ovarian stimulator, egg retrieval and fertilization, culture of embryos, and transfer. Our fertility specialists closely monitor every step of the process to create a customized treatment plan to meet the needs of each patient and enhance their chances of success.

When is IVF Treatment Recommended?

IVF treatment should generally be considered by women under 43 who have tried for two years to conceive with unprotected sexual relations without success. These treatments can help treat infertility caused by blocked fallopian tubes, genetic issues or male infertility factors. In some cases, less invasive procedures such as fertility drugs or intrauterine insemination may be tried first. However, IVF treatment in Kolkata may be recommended to women in their mid-30s when other options have failed or when other health conditions such as fallopian tube damage, ovulation disorders, endometriosis, uterine fibroids, previous tubal sterilization or removal, impaired sperm function, unexplained infertility, genetic disorders, or for fertility preservation due to cancer or other health conditions. Therefore it is wise to discuss all available treatments with a fertility specialist prior to embarking upon IVF therapy treatment plan In Kolkata. It is important to discuss all available options with a fertility specialist to determine the best course of IVF treatment In Kolkata.

Why Choose IHR India For IVF treatment in Kolkata?

At IHR Kolkata, we offer the best ivf specialist in india, providing couples struggling with infertility the opportunity to achieve their dream of having a child. We use advanced medical technologies and modern infrastructure to offer personalized treatment plans tailored to the unique needs of each patient. Our team of experienced and caring medical staff works closely with patients at every step, providing support and guidance throughout their fertility journey. With a high success rate of 70%, we are a leading choice for both domestic and international patients that are seeking for ivf specialist in kolkata. We are committed to making superior infertility treatments that are affordable and accessible to a larger population, helping more couples fulfill their dream of parenthood.

Our team of experts, fertility breakthrough results and a 70% success rate made us a unique option for desired couples. We are trying our best to make superior infertility treatments inexpensive to a larger population.

Reasons To Choose Us:

1. We are passionate about helping infertile couples with our definite solutions.

2. All our methods are well-tested and tried.

3. We always focus on reducing the mental and physical stress of our patient so that they go successfully in their IVF treatment.

4. Our medical staff is supportive and help you in every step of your IVF fertility journey.

5. We deliver supreme services for male and female infertility that results in better outcomes for both mothers and babies.

Do you have difficulty conceiving a child? Couples who have failed to conceive using other methods often consider IVF treatment in Kolkata. Here are some reasons why couples consider IVF treatment:

1. Tubal Factor: When the fallopian tubes become blocked or damaged, IVF may be the only viable way to achieve pregnancy. Since the fallopian tubes connect ovaries to womb, and an egg cannot travel down them without impediments, pregnancy cannot occur naturally.

2. Male Infertility: It is a common reason for infertility in couples. If the male partner has low sperm count or abnormalities that hinder fertilization of the egg, IVF with ICSI is frequently recommended for a successful pregnancy and biological baby.

3. Age-related Infertility: As women age, their ovarian function decreases and they may find it increasingly difficult to get pregnant. Some women’s ovarian function decreases earlier, making it necessary to consider IVF treatment sooner.

4. PCOS: Patients living with Polycystic Ovary Syndrome (PCOS) frequently have difficulty becoming pregnant. IVF treatment may be beneficial and help lower some risk factors.

5. Undetermined Infertility: Approximately 20% of couples experience unexplained infertility, without any identifiable reason. IVF treatment has proven to be successful in such cases.

6. Genetic Disease: Couples suffering from genetic disorders who experience repeated miscarriages should consider IVF treatment as the only option for a successful pregnancy.

[cafolilifecare]

Gynae PCD Pharma Franchise in India

1. Introduction

India’s pharmaceutical sector has experienced phenomenal growth over the past few decades, establishing itself as the “pharmacy of the world.” Within this thriving industry, the gynaecology (Gynae) segment has seen a sharp rise in demand. Factors such as increased healthcare awareness, greater focus on women’s wellness, improved access to healthcare services, and evolving lifestyle patterns have contributed to the soaring need for high-quality gynaecological medicines.

The Gynae pharmaceutical sector addresses critical aspects of women’s reproductive health, fertility, prenatal and postnatal care, menstrual health, hormonal balance, and general wellness. Given India’s large female population and the rising emphasis on women’s health, the Gynae market presents a lucrative opportunity for businesses.

For entrepreneurs seeking a profitable and sustainable business model, partnering with a reputable Gynae PCD Pharma Company like Cafoli offers tremendous scope for growth and success.

1. What is Gynae (Gynaecology)?

Gynecology is a branch of medical science that deals with the health of the female reproductive system, including the uterus, ovaries, fallopian tubes, and vagina. It also focuses on issues related to menstruation, fertility, pregnancy, childbirth, and menopause. A doctor who specialises in this field is known as a gynaecologist.

2. Importance of Gynaecology in Healthcare

Gynaecology is essential for maintaining women’s health at every stage of life. Gynaecological care helps women manage reproductive health, hormonal issues, and fertility from adolescence to old age.

A. Key Areas of Focus:

Menstrual disorders (irregular, heavy, or painful periods)

Pregnancy and childbirth

Fertility and conception

Contraception and family planning

Sexually transmitted infections (STIs)

Menopause and hormonal changes

Gynaecological cancers (cervical, ovarian, uterine)

3. Common Gynae Medications and Treatments

Pharmaceutical companies manufacture a wide range of gynaecology-specific products. These include:

Hormonal tablets — for contraceptives, menopause, and menstrual regulation

Fertility medicines — to assist with ovulation and conception

Antibiotics and antifungals — to treat infections

Prenatal and postnatal supplements — such as iron, calcium, and folic acid

Injectables — hormonal injections and IVF-related drugs

Personal hygiene products — vaginal washes, creams, wipes

4. Why Gynae is a High-Growth Sector in Pharma

1. Rising Women’s Health Awareness

More women are now aware of the importance of regular gynaecological checkups and treatments, especially in urban areas.

2. Increased Demand for Reproductive Health Solutions

With changing lifestyles and increasing infertility rates, there is a rising need for fertility treatments and hormone therapy.

3. Government and NGO Initiatives

Health programs focused on maternal and reproductive health are boosting demand for gynaecology products in both urban and rural India.

4. Scope for PCD Pharma Franchise

Due to the vast and increasing demand, Gynae PCD Pharma Franchise opportunities have grown across India, offering entrepreneurs the chance to sell gynaecology products under well-known pharma brands.

5. What is a PCD Pharma Franchise?

The term PCD (Propaganda Cum Distribution) refers to a business model where a pharma company authorizes an individual, group, or organization to promote and distribute its products using the company’s brand name and support.

How it Works:

The company (like Cafoli) provides high-quality pharmaceutical products and marketing materials.

The franchise partner markets and sells these products in an assigned area.

The partner enjoys monopoly rights for the assigned region, ensuring no competition from the same brand.

6. Benefits for Franchise Partners:

Low Investment, High Returns: Start with minimal risk and reap good profits.

Monopoly Rights: Exclusive distribution rights in your territory.

Established Brand Support: Benefit from Cafoli’s strong brand reputation.

No Sales Targets: Work at your own pace without pressure.

Wide Product Portfolio: More options to cater to doctors and hospitals.

7. Market Scope for Gynae PCD Franchise

The Indian Gynae pharmaceutical market is expanding rapidly, driven by:

1. Growing Awareness:

Women are increasingly proactive about their health. Campaigns promoting reproductive and menstrual health have broken taboos, leading to higher demand for gynaecological products.

2. Increasing Gynaecological Disorders:

Health concerns like PCOS, infertility, menstrual disorders, and hormonal imbalances are rising. This necessitates a reliable supply of gynecological treatments.

3. Pregnancy and Fertility Care:

With increased family planning awareness and healthcare facilities, the demand for prenatal and postnatal products is booming.

8. Urban vs. Rural Opportunities:

Urban Areas: Focus on advanced treatments, fertility care, and hormonal therapies.

Rural Areas: Emphasis on basic healthcare, prenatal care, hygiene products.

The Gynae PCD sector offers vast potential in both settings, making it a highly attractive business proposition.

9. Product Range in Gynae Segment

Cafoli offers an extensive and diverse range of Gynae products to meet every aspect of women’s health:

1. Tablets, Capsules, and Syrups:

Iron supplements

Calcium tablets

Hormonal balance medicines

Antibiotics and antifungals

2. Hormonal Therapies:

Hormone Replacement Therapy (HRT) products

Birth control and contraceptive pills

3. Injectables:

Infertility treatment injections

Vitamin and nutrient shots

4. Prenatal and Postnatal Care:

Multivitamin and mineral supplements

DHA, folic acid, and iron supplements

Post-delivery care medicines

5. Hygiene and Fertility Products:

Vaginal washes

Personal hygiene solutions

Ovulation kits

This comprehensive range ensures that franchise partners can meet a wide spectrum of medical needs under one roof.

10. Legal Requirements

To start a Gynae PCD Pharma Franchise in India, you must adhere to specific legal norms:

1. Drug License:

Mandatory to sell, distribute, and stock pharmaceutical products.

2. GST Registration:

Required to operate legally and manage tax compliance.

3. Franchise Agreement:

A formal agreement between Cafoli and the franchise partner, specifying terms such as area rights, payment conditions, and obligations.

Cafoli ensures a transparent onboarding process to help partners fulfill all necessary compliance requirements easily.

11. Selection of Gynae PCD Company

Choosing the right pharma company is crucial for success. Here’s why Cafoli stands out:

1. Reputation and Certifications:

ISO-certified company

WHO-GMP approved manufacturing facilities

Trusted by healthcare professionals

2. Wide Product Portfolio:

Cafoli offers a carefully curated, high-demand range of Gynae products covering prenatal, postnatal, fertility, and hygiene segments.

3. Monopoly Rights:

Cafoli offers district-wise and territory-wise exclusive rights.

No internal competition for your assigned area.

4. Promotional Support:

High-quality marketing materials like brochures, MR bags, visiting cards, visual aids, and sample kits.

Attractive and premium packaging that enhances brand image.

All these factors position Cafoli as a preferred partner for Gynae PCD Pharma ventures in India.

12. Investment and Profit Margin

1. Initial Investment:

Starting a Gynae PCD franchise with Cafoli requires an investment between ₹25,000 and ₹1,00,000, depending on product selection and territory size.

2. Profit Margins:

Typically 20–40% margins.

Highly profitable as Gynae products are essential and repeat purchases are common.

3. Return on Investment (ROI):

Quick break-even (within 6–12 months) when marketed well.

Cafoli’s strong product credibility speeds up doctors’ acceptance and patient prescriptions.

Thus, minimal investment can yield sustainable, long-term returns.

13. Monopoly Rights and Territory Allocation

Monopoly rights are crucial for a stress-free business:

A. Why Monopoly Matters:

No brand competition in your territory.

Freedom to build strong doctor-hospital relations.

B. Terms & Conditions:

Cafoli provides clear documentation specifying the covered area.

Partners are encouraged to expand within their territory for maximum sales.

This approach enhances profitability while allowing franchisees to work independently.

14. Marketing and Promotional Support

Cafoli believes in empowering its partners with world-class marketing support:

1. Visual Aids:

Detailed product information aids for Medical Representatives to showcase to doctors.

2. MR Bags and Samples:

Professionally designed MR kits and product samples to leave with healthcare providers.

3. Visiting Cards and Order Books:

Personalised visiting cards and easy-to-use order books for smooth operations.

4. Digital Support (Optional):

Cafoli can assist partners with digital marketing strategies.

Helping create an online presence via SEO, social media, and paid ads.

With strong marketing support, franchisees can make a significant mark in their regions.

15. Challenges and Solutions

While the Gynae PCD business is lucrative, it comes with its challenges:

1. Competition:

Solution:

Focus on relationship-building with healthcare providers.

Offer quality products with better service and support.

2. Product Quality Assurance:

Solution:

Partner only with certified companies like Cafoli with WHO-GMP, ISO certifications ensuring stringent quality controls.

3. Building Trust:

A. Solution:

Regular visits to doctors, providing timely supplies, and offering excellent after-sales service.

Cafoli’s proven model and support system help franchisees tackle these challenges effectively.

16. Why Choose Cafoli for Gynae PCD Franchise?

Cafoli is not just another pharma company; it’s a name synonymous with quality, trust, and innovation in the pharmaceutical sector.

Key Reasons:

WHO-GMP Certified Manufacturing: Assurance of international quality standards.

Innovative Product Development: Regular product updates based on market needs.

Attractive Packaging: High-quality, premium packaging that appeals to doctors and patients.

Customer-Centric Approach: Cafoli believes in building long-term relationships with its franchise partners, offering end-to-end business support.

Affordable Pricing: Competitive pricing without compromising on quality.

Choosing Cafoli means securing a future-proof business with strong backend support and excellent product credibility.

17. Key Qualities Needed to Succeed in Gynae PCD Business

Success in the Gynae PCD pharma business is not accidental; it demands certain qualities and strategies:

Strong Networking: Building personal relationships with gynaecologists and healthcare centers.

Consistency: Regular follow-ups with healthcare providers.

Product Knowledge: A Detailed understanding of products helps in convincing doctors.

Customer Service: Providing timely delivery and solving queries.

Marketing Savvy: Using digital platforms, social media, and offline marketing strategies effectively.

Entrepreneurs who focus on these areas can achieve consistent growth and profitability.

18. Future Trends in Gynae Pharmaceutical Market

The future of the Gynae segment looks very promising, with new trends shaping the industry:

Rise in Fertility Treatments: Increased focus on IVF and fertility-related treatments.

Menstrual Health Innovations: New products focusing on menstrual wellness and hygiene.

Natural and Organic Products: Demand for herbal, organic, and chemical-free products.

Telemedicine Growth: Doctors consulting online is leading to faster medicine prescriptions.

Increased Awareness of Women’s Mental Health: Demand for products that support hormonal and emotional balance.

Cafoli constantly innovates to stay ahead of these trends and offers partners future-ready products.

Conclusion

The Gynae PCD Pharma Franchise model in India is more than just a profitable venture — it’s a mission-driven opportunity to contribute meaningfully to women’s health. With the increasing demand for high-quality gynecological products, shifting societal perspectives on women’s wellness, and expanding healthcare access in both urban and rural sectors, the potential for business growth is enormous.

Cafoli stands out as a trusted partner with its WHO-GMP-certified manufacturing, wide product range, competitive pricing, and robust marketing support. Whether you’re an aspiring entrepreneur or a seasoned pharma professional, joining hands with Cafoli can open the door to a rewarding and sustainable career in the healthcare industry.

In the coming years, the gynecology segment will see more innovation, better awareness, and growing acceptance. Those who invest now — armed with the right strategy, support, and products — are well-positioned to become market leaders in their territory.

Final Thoughts

If you are looking for a low-risk, high-reward business opportunity that also makes a positive impact on society, a Gynae PCD Pharma Franchise with Cafoli is your ideal choice. With a supportive ecosystem, future-ready product line, and area-wise monopoly rights, success is not just possible — it’s predictable.

Start your journey with Cafoli and play a vital role in shaping the future of women’s healthcare across India

Explore our various products at https://cafoli.in, including specialised offerings https://cafoli.in/allproduct.aspx

[dramitsaklanijalandhar]

Expert Cancer Care in Jalandhar – Dr. Amit Saklani

Cancer, a life-altering disease, requires not only timely diagnosis and advanced treatment but also the compassionate care of a dedicated specialist. In Jalandhar, Dr. Amit Saklani stands out as a trusted name in the field of Oncology, offering hope and healing to patients battling various types of cancer.

With years of clinical experience and a commitment to excellence, Dr. Amit Saklani provides personalized and evidence-based treatment plans tailored to each patient’s specific cancer type and condition.

👨‍⚕️ About Dr. Amit Saklani

Dr. Amit Saklani is a renowned Cancer Specialist (Oncologist) in Jalandhar, known for his extensive experience in diagnosing and treating a wide range of cancers. With a focus on delivering comprehensive cancer care, he utilizes cutting-edge technologies and multidisciplinary treatment approaches to ensure the best possible outcomes.

✅ Specialization:

Medical Oncology

Chemotherapy

Targeted Therapy

Immunotherapy

Supportive & Palliative Care

✅ Treatment Areas:

Breast Cancer

Lung Cancer

Prostate Cancer

Colon & Rectal Cancer

Blood Cancers (Leukemia, Lymphoma)

Head and Neck Cancers

Gynecologic Cancers (Ovarian, Cervical, Uterine)

Pediatric Cancers

🧬 Comprehensive Cancer Treatment Services

Dr. Amit Saklani offers a full spectrum of cancer care, from early diagnosis to advanced treatment and follow-up:

🔹 Diagnosis:

Clinical examination

Imaging (CT, MRI, PET Scan)

Biopsy & Histopathology

Tumor marker testing

🔹 Treatment:

Chemotherapy: The most common and effective cancer treatment using anti-cancer drugs

Targeted Therapy: Focuses on specific molecules involved in cancer growth

Immunotherapy: Boosts the body's immune system to fight cancer

Hormonal Therapy: Used especially in breast and prostate cancers

Palliative Care: Relief from cancer symptoms and side effects of treatment

❤️ Why Choose Dr. Amit Saklani for Cancer Treatment in Jalandhar?

✅ Compassionate and patient-centered approach

✅ Up-to-date with the latest oncological research and treatments

✅ High success rate with tailored treatment protocols

✅ Strong focus on quality of life and long-term survivorship

✅ Clear communication and complete guidance throughout the cancer journey

🏥 Hospital Association

Dr. Amit Saklani is associated with one of the leading cancer care centers in Jalandhar, equipped with modern facilities, a dedicated oncology team, and patient-friendly services.

Consultation available for:

New cancer diagnosis

Second opinions

Ongoing chemotherapy cycles

Follow-up care and monitoring

📍 Location & Contact

Dr. Amit Saklani – Cancer Specialist (Oncologist) 📍 Jalandhar, Punjab Patel Hospital, Civil Lines Jalandhar, Panjab 144001 📞 Contact Number  - 9339026214  /  9268880303

🌐 Website - https://saklanioncology.com/        

🔔 Don’t Delay – Early Diagnosis Can Save Lives

Cancer is most treatable when detected early. If you or your loved one is experiencing symptoms such as unusual lumps, unexplained weight loss, chronic fatigue, persistent pain, or abnormal bleeding, get evaluated without delay.

Dr. Amit Saklani is here to guide you with expert medical advice, modern cancer therapies, and unwavering support throughout your treatment journey.

Choose hope. Choose expert care. Choose Dr. Amit Saklani.

[kathleencampbelldavis]

How Mass Torts Function in US Courts

Mass torts are civil actions that many individual plaintiffs bring against a small number, or only one, defendant in a court of law. Often centered around accidents and defective products, they provide an efficient way of enabling many victims to obtain justice and receive financial compensation for their losses and injuries. Some of the distinct types of mass torts are those involving dangerous drugs, product liability, defective medical devices, and toxic exposure. They may also center on major accidents such as an airplane crash, explosion, fire, or train wreck.

Mass torts share two central features that set them apart from other types of product liability cases. They have commonality when it comes to actors and issues. In addition, there is strong interdependence in case values. Often many claims arise across a limited number of jurisdictions within a relatively short timeframe. Claims tend to be brought to court by a handful of law firms and are often managed by a single, or limited number, of judges. A defined team of experts and special masters provides support to the judges.

Mass torts are not the same as class action lawsuits. The latter are filed on behalf of a class of plaintiffs with similar claims and/or injuries, with one or a small group of people heading the lawsuit. These represent the entire class, with every participant in the suit receiving the same monetary compensation when a settlement is achieved. With mass torts, each person files a separate lawsuit and receives a differing amount of compensation, reflecting their specific injury.

Mass personal injury litigation presents several challenges, including the often protracted time until resolution and uncertainty about the likely outcome and its expected value. Attorneys must carefully assess cases at hand and make sure that the risks of failure, or receiving minimal compensation, are not too great.

In addition, proving a causal link between product exposure and use, and latent injuries suffered, can be challenging. Scientific evidence may be extremely complex or lacking, and how the jury and judge will respond to evidence cannot always be predicted. Plaintiffs' attorneys also need to establish legal responsibility among defendants for injuries. Demonstrating that a case carries substantial monetary value is difficult, as several jury trials may be required.

The mass tort process is protracted and often involves the use of bellwether trials. These individual trials serve as a benchmark or trial of how the jury or judge reacts to the case and provide a predictive mechanism for the ultimate resolution of remaining cases. These trials may serve as a basis for a settlement that saves plaintiffs and defendants the substantial costs associated with an extended court battle.

There are several high-profile mass torts ongoing within the US judicial system. In early 2025, one centers on hair-straightening products that may increase a person’s uterine cancer risks significantly. Another represents more than 1,800 multidistrict claims filed with the Eastern District of New York and involves Exactech knee and ankle replacements, These were recalled, as they contained polyethylene inserts with packaging that resulted in the inserts deteriorating. Other ongoing mass torts center firefighting foam, baby formula linked with necrotizing enterocolitis, and Talcum powder.